Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
NovoCure
NVCR
$2.02B
| $4.99M | ﹤0.01% |
279,912
-180,143
| -39% | -$4.09M |
|
|
AKRO
1902
DELISTED
Akero Therapeutics
AKRO
| $4.99M | ﹤0.01% |
123,163
-9,674
| -7% | -$410K |
|
|
DMX
1903
DoubleLine Multi-Sector Income ETF
DMX
$101M
| $4.98M | ﹤0.01% |
100,000
| – | – |
|
|
CVSA
1904
Covista Inc
CVSA
$4.49B
| $4.97M | ﹤0.01% |
49,412
-17,344
| -26% | -$1.73M |
|
1905
Ashland
ASH
$3.36B
| $4.97M | ﹤0.01% |
83,847
-9,575
| -10% | -$610K |
|
1906
StepStone Group
STEP
$4.28B
| $4.97M | ﹤0.01% |
95,101
-36,119
| -28% | -$2.12M |
|
1907
Avient
AVNT
$4.23B
| $4.97M | ﹤0.01% |
133,622
-80,599
| -38% | -$3.33M |
|
1908
CALL
Pinterest
PINS
$13.2B
| $4.96M | ﹤0.01% |
+160,000
| New | +$5.42M |
|
1909
GameStop
GME
$8.33B
| $4.96M | ﹤0.01% |
222,137
-92,078
| -29% | -$2.41M |
|
1910
SiteOne Landscape Supply
SITE
$4.27B
| $4.95M | ﹤0.01% |
40,755
+10,987
| +37% | +$1.46M |
|
1911
Qfin Holdings
QFIN
$1.52B
| $4.95M | ﹤0.01% |
110,191
-35,135
| -24% | -$1.45M |
|
1912
Andersons Inc
ANDE
$2.21B
| $4.95M | ﹤0.01% |
115,206
+9,897
| +9% | +$421K |
|
|
VNET
1913
VNET Group
VNET
$2.12B
| $4.94M | ﹤0.01% |
602,299
+595,206
| +8,391% | +$5.46M |
|
1914
TFI International
TFII
$12.1B
| $4.93M | ﹤0.01% |
63,707
+63,529
| +35,690% | +$7.03M |
|
1915
Summit Therapeutics
SMMT
$11.2B
| $4.93M | ﹤0.01% |
255,612
-74,534
| -23% | -$1.5M |
|
1916
Popular Inc
BPOP
$11.3B
| $4.92M | ﹤0.01% |
53,262
-25,294
| -32% | -$2.46M |
|
1917
CALL
Teck Resources
TECK
$31.3B
| $4.92M | ﹤0.01% |
135,000
-265,000
| -66% | -$11M |
|
1918
Kontoor Brands
KTB
$4.65B
| $4.91M | ﹤0.01% |
76,622
-28,148
| -27% | -$2.18M |
|
1919
Atlantic Union Bankshares
AUB
$6.09B
| $4.91M | ﹤0.01% |
157,794
-45,179
| -22% | -$1.61M |
|
1920
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $4.91M | ﹤0.01% |
64,114
-10,340
| -14% | -$780K |
|
1921
PBF Energy
PBF
$8.81B
| $4.9M | ﹤0.01% |
256,722
-18,616
| -7% | -$463K |
|
1922
Trex
TREX
$5.1B
| $4.9M | ﹤0.01% |
84,277
-25,183
| -23% | -$1.64M |
|
1923
Braze
BRZE
$3.36B
| $4.9M | ﹤0.01% |
135,704
+18,206
| +15% | +$733K |
|
|
RDFN
1924
DELISTED
Redfin
RDFN
| $4.89M | ﹤0.01% |
531,353
+172,119
| +48% | +$1.47M |
|
1925
Urban Edge Properties
UE
$2.78B
| $4.89M | ﹤0.01% |
257,376
+19,514
| +8% | +$390K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.